
    
      Participants with WHO Category II exposure will receive PEP, using "one-week, 4-site" ID
      vaccination regimen. Participants with WHO Category III exposure will receive PEP, using
      "one-week, 4-site" (4-4-4-0-0) ID vaccination regimen and pERIG Favirab® or using the updated
      2-site TRC (2-2-2-0-2) ID vaccination regimen and pERIG Favirab®. All participants will
      receive a "single-visit, 4-site" booster vaccination five years later.
    
  